NO20082733L - Indol-3-yl-karbonyl-spiro-piperidinderivater - Google Patents
Indol-3-yl-karbonyl-spiro-piperidinderivaterInfo
- Publication number
- NO20082733L NO20082733L NO20082733A NO20082733A NO20082733L NO 20082733 L NO20082733 L NO 20082733L NO 20082733 A NO20082733 A NO 20082733A NO 20082733 A NO20082733 A NO 20082733A NO 20082733 L NO20082733 L NO 20082733L
- Authority
- NO
- Norway
- Prior art keywords
- indol
- carbonyl
- spiropiperidine
- spiro
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06100118 | 2006-01-05 | ||
PCT/EP2006/069897 WO2007077122A1 (fr) | 2006-01-05 | 2006-12-19 | Derives d'indol-3-yl-carbonyl-spiro-piperidine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082733L true NO20082733L (no) | 2008-10-02 |
Family
ID=37989141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082733A NO20082733L (no) | 2006-01-05 | 2008-06-18 | Indol-3-yl-karbonyl-spiro-piperidinderivater |
Country Status (15)
Country | Link |
---|---|
US (1) | US7351706B2 (fr) |
EP (1) | EP1973913A1 (fr) |
JP (1) | JP2009522318A (fr) |
KR (1) | KR101121349B1 (fr) |
CN (1) | CN101356174B (fr) |
AR (1) | AR059136A1 (fr) |
AU (1) | AU2006334423B2 (fr) |
BR (1) | BRPI0620951A2 (fr) |
CA (1) | CA2634120A1 (fr) |
IL (1) | IL192401A0 (fr) |
NO (1) | NO20082733L (fr) |
RU (1) | RU2420529C2 (fr) |
TW (1) | TW200734343A (fr) |
WO (1) | WO2007077122A1 (fr) |
ZA (1) | ZA200805574B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6374762B1 (en) * | 1997-10-27 | 2002-04-23 | Correct Craft, Inc. | Water sport towing apparatus |
MX2007002033A (es) | 2004-08-19 | 2007-04-26 | Vertex Pharma | Moduladores de receptores muscarinicos. |
US7786141B2 (en) * | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
RU2007124373A (ru) * | 2004-11-29 | 2009-01-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецептеров |
WO2007039438A1 (fr) * | 2005-09-28 | 2007-04-12 | F. Hoffmann-La Roche Ag | Composés indol-3-ylcarbonylazaspiro en tant qu'antagonistes du récepteur de la vasopressine |
JP2009521483A (ja) * | 2005-12-22 | 2009-06-04 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体のモジュレーター |
RU2008137593A (ru) * | 2006-02-22 | 2010-03-27 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецепторов |
EP2051712A2 (fr) * | 2006-08-15 | 2009-04-29 | Vertex Pharmceuticals Incorporated | Modulateurs de récepteurs muscariniques |
JP2010501561A (ja) * | 2006-08-18 | 2010-01-21 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体の調節剤 |
DE602007006989D1 (en) * | 2006-12-07 | 2010-07-15 | Hoffmann La Roche | Spiropiperidinderivate |
EP2207549A1 (fr) * | 2007-10-03 | 2010-07-21 | Vertex Pharmceuticals Incorporated | Modulateurs des récepteurs muscariniques |
US8846684B2 (en) | 2011-03-31 | 2014-09-30 | The Regents Of The University Of Michigan | Arbovirus inhibitors and uses thereof |
CA2866218C (fr) | 2012-03-16 | 2020-06-09 | Vitae Pharmaceuticals, Inc. | Modulateurs du recepteur x du foie |
DK2825542T3 (en) | 2012-03-16 | 2017-01-09 | Vitae Pharmaceuticals Inc | LIVER-X-receptor modulators |
BR112016013058B1 (pt) | 2013-12-19 | 2021-02-23 | F. Hoffmann-La Roche Ag | Espiro-oxazolonas, seus usos, seus intermediários e composiçãofarmacêutica |
ES2951874T3 (es) * | 2017-09-05 | 2023-10-25 | Neumora Therapeutics Inc | Antagonistas del receptor de vasopresina y productos y métodos relacionados con los mismos |
WO2020048828A1 (fr) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | Composés du 5-hétéroaryl-3,9-diazaspiro[5.5]undécane |
WO2020048826A1 (fr) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | Composés de la 1-oxa-3,9-diazaspiro[5.5]undécan-2-one substituée en position 5 |
WO2020048831A1 (fr) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | Composés 5-aryl-3,9-diazaspiro[5.5]undécan-2-one |
WO2020048829A1 (fr) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | Composés de 3,9-diazaspiro[5.5]undécane |
WO2020048830A1 (fr) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | Composés 5-aryl-3,9-diazaspiro[5.5]undécan-2-one |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4349549A (en) * | 1981-05-18 | 1982-09-14 | Syntex (U.S.A.) Inc. | Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s |
CA2298813A1 (fr) | 1997-08-28 | 1999-03-04 | Merck & Co., Inc. | Modulateurs de pyrrolidine et de piperidine de l'activite du recepteur de chemokine |
US6013652A (en) | 1997-12-04 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin antagonists |
WO2001022919A2 (fr) | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Derives de spiro[azacycloalkyle et cycloalkyle bicycliques] et utilisations de ceux-ci |
GB0003397D0 (en) | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
SI1549638T1 (sl) | 2002-10-03 | 2008-02-29 | Hoffmann La Roche | Indol-3-karboksiamidi kot aktivatorji glukokinaze(gk) |
RU2414466C2 (ru) | 2005-07-14 | 2011-03-20 | Ф. Хоффманн-Ля Рош Аг | ПРОИЗВОДНЫЕ ИНДОЛ-3-КАРБОНИЛ-СПИРО-ПИПЕРИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРОВ V1a |
-
2006
- 2006-12-18 US US11/640,739 patent/US7351706B2/en not_active Expired - Fee Related
- 2006-12-19 RU RU2008125813/04A patent/RU2420529C2/ru not_active IP Right Cessation
- 2006-12-19 EP EP06841445A patent/EP1973913A1/fr not_active Withdrawn
- 2006-12-19 KR KR1020087016220A patent/KR101121349B1/ko not_active IP Right Cessation
- 2006-12-19 JP JP2008548964A patent/JP2009522318A/ja not_active Ceased
- 2006-12-19 BR BRPI0620951-3A patent/BRPI0620951A2/pt not_active IP Right Cessation
- 2006-12-19 CN CN2006800504473A patent/CN101356174B/zh not_active Expired - Fee Related
- 2006-12-19 AU AU2006334423A patent/AU2006334423B2/en not_active Ceased
- 2006-12-19 WO PCT/EP2006/069897 patent/WO2007077122A1/fr active Application Filing
- 2006-12-19 CA CA002634120A patent/CA2634120A1/fr not_active Abandoned
-
2007
- 2007-01-02 TW TW096100068A patent/TW200734343A/zh unknown
- 2007-01-04 AR ARP070100032A patent/AR059136A1/es not_active Application Discontinuation
-
2008
- 2008-06-18 NO NO20082733A patent/NO20082733L/no not_active Application Discontinuation
- 2008-06-23 IL IL192401A patent/IL192401A0/en unknown
- 2008-06-25 ZA ZA200805574A patent/ZA200805574B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2008125813A (ru) | 2010-02-10 |
EP1973913A1 (fr) | 2008-10-01 |
US20070155761A1 (en) | 2007-07-05 |
TW200734343A (en) | 2007-09-16 |
KR20080073364A (ko) | 2008-08-08 |
IL192401A0 (en) | 2008-12-29 |
US7351706B2 (en) | 2008-04-01 |
CN101356174A (zh) | 2009-01-28 |
AU2006334423A1 (en) | 2007-07-12 |
WO2007077122A1 (fr) | 2007-07-12 |
CN101356174B (zh) | 2011-11-23 |
RU2420529C2 (ru) | 2011-06-10 |
AR059136A1 (es) | 2008-03-12 |
BRPI0620951A2 (pt) | 2011-11-29 |
JP2009522318A (ja) | 2009-06-11 |
ZA200805574B (en) | 2009-12-30 |
CA2634120A1 (fr) | 2007-07-12 |
AU2006334423B2 (en) | 2011-09-22 |
KR101121349B1 (ko) | 2012-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082733L (no) | Indol-3-yl-karbonyl-spiro-piperidinderivater | |
NO20080059L (no) | Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister | |
NO20080316L (no) | Indol-3-yl-karbonylpiperidin- og piperazinderivater | |
NO20080291L (no) | Indol-3-yl-karbonyl-piperidin-benzomidazolderivater som Via reseptorantagonister | |
NO20071660L (no) | Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer | |
NO20083500L (no) | 1,4-disubstituerte 3-cyano-pyridonderivater og deres anvendelse som positiv-allosteriske modulatorer av mGluR2 receptorer | |
WO2006021213A3 (fr) | Antagonistes de récepteur v1a la vasopressine v1a | |
NO20064579L (no) | Bifenylforbindelser anvendelige som muskariniske receptorantagonister | |
NO20083909L (no) | Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere | |
WO2007020213A3 (fr) | Derives de thiazolylpiperidines | |
NO20092762L (no) | 2-aza-bicyklo[3.1.0]heksanderivater | |
NO20076060L (no) | Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister | |
WO2010036613A8 (fr) | Nouveaux dérivés de benzimidazole cycliques utiles en tant qu'agents anti-diabétiques | |
CY1108880T1 (el) | Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
JPWO2006051826A1 (ja) | 含窒素複素環化合物およびその医薬用途 | |
NO20063597L (no) | Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
WO2008099072A3 (fr) | Nouveaux derives de 2, 4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk | |
TW200640863A (en) | Compounds which potentiate glutamate receptor and uses thereof in medicine | |
NO20091831L (no) | Indoler | |
WO2008145524A3 (fr) | Dérivés de pipéridine 4,4-disubstituée | |
MY139016A (en) | PYRAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF ß-ADRENERGIC RECEPTOR KINASE 1 | |
NO20091832L (no) | Indoler som virker via reseptorantagonister | |
NO20063562L (no) | Fusjonerte heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
WO2009034432A3 (fr) | Nouveaux composés actifs utilisés comme antagonistes des récepteurs muscariniques | |
NO20092264L (no) | Spiro-piperidinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |